These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 38749341

  • 1. Discovery of indole-2-one derivatives as BRD4 (BD1) selective inhibitors.
    Qiao XP, Wang XT, Wang S, Mu HX, Wang QS, Chen SW.
    Bioorg Med Chem; 2024 May 15; 106():117752. PubMed ID: 38749341
    [Abstract] [Full Text] [Related]

  • 2. Design, synthesis and biological evaluation of indole-2-one derivatives as potent BRD4 inhibitors.
    Xu Y, Zhang XJ, Li WB, Wang XR, Wang S, Qiao XP, Chen SW.
    Eur J Med Chem; 2020 Dec 15; 208():112780. PubMed ID: 32883643
    [Abstract] [Full Text] [Related]

  • 3. Discovery of the natural product 3',4',7,8-tetrahydroxyflavone as a novel and potent selective BRD4 bromodomain 2 inhibitor.
    Li J, Zou W, Yu K, Liu B, Liang W, Wang L, Lu Y, Jiang Z, Wang A, Zhu J.
    J Enzyme Inhib Med Chem; 2021 Dec 15; 36(1):903-913. PubMed ID: 33820450
    [Abstract] [Full Text] [Related]

  • 4. Binding pocket-based design, synthesis and biological evaluation of novel selective BRD4-BD1 inhibitors.
    Ma J, Chen H, Yang J, Yu Z, Huang P, Yang H, Zheng B, Liu R, Li Q, Hu G, Chen Z.
    Bioorg Med Chem; 2019 May 01; 27(9):1871-1881. PubMed ID: 30926312
    [Abstract] [Full Text] [Related]

  • 5. Discovery of 3,5-dimethylisoxazole derivatives as novel, potent inhibitors for bromodomain and extraterminal domain (BET) family.
    Fang L, Hu Z, Yang Y, Chen P, Zhou J, Zhang H.
    Bioorg Med Chem; 2021 Jun 01; 39():116133. PubMed ID: 33862375
    [Abstract] [Full Text] [Related]

  • 6. Design, synthesis and biological evaluation of novel 6-phenyl-1,3a,4,10b-tetrahydro-2H-benzo[c]thiazolo[4,5-e]azepin-2-one derivatives as potential BRD4 inhibitors.
    Li Q, Li J, Cai Y, Zou Y, Chen B, Zou F, Mo J, Han T, Guo W, Huang W, Qiu Q, Qian H.
    Bioorg Med Chem; 2020 Aug 01; 28(15):115601. PubMed ID: 32631570
    [Abstract] [Full Text] [Related]

  • 7. Design, synthesis, and biological activity evaluation of a series of novel sulfonamide derivatives as BRD4 inhibitors against acute myeloid leukemia.
    Feng Z, Chen A, Shi J, Zhou D, Shi W, Qiu Q, Liu X, Huang W, Li J, Qian H, Zhang W.
    Bioorg Chem; 2021 Jun 01; 111():104849. PubMed ID: 33798846
    [Abstract] [Full Text] [Related]

  • 8. Design, synthesis, and biological evaluation of novel 4,4-difluoro-1-methyl-N, 6-diphenyl-5, 6-dihydro-4H-pyrimido [4, 5-b] [1, 2, 4] triazolo [4, 3-d] [1, 4] diazepin-8-amine derivatives as potential BRD4 inhibitors.
    Li J, Zhang W, Qiu Q, Zhou D, Feng Z, Tong Z, Wei J, Huang W, Li J, Qian H, Shi W.
    Chem Biol Drug Des; 2021 May 01; 97(5):1117-1128. PubMed ID: 33638254
    [Abstract] [Full Text] [Related]

  • 9. Discovery of a potent orally available pyrazolopyridone derivative as a novel selective bromodomain and extra-terminal domain (BET)-first bromodomain (BD1) inhibitor.
    Hagihara S, Ishizawa K, Soga K, Honjo T, Takai S, Kawano Y, Kikuchi M, Nishidate A, Matsumoto F, Murase M, Hashimoto N, Sasaki C, Miyaguchi I, Okada O, Akashi T, Nakayama S, Ogasawara Y, Endo J.
    Bioorg Med Chem Lett; 2024 Sep 01; 109():129849. PubMed ID: 38876177
    [Abstract] [Full Text] [Related]

  • 10. Discovery of a series of dihydroquinoxalin-2(1H)-ones as selective BET inhibitors from a dual PLK1-BRD4 inhibitor.
    Hu J, Wang Y, Li Y, Xu L, Cao D, Song S, Damaneh MS, Wang X, Meng T, Chen YL, Shen J, Miao Z, Xiong B.
    Eur J Med Chem; 2017 Sep 08; 137():176-195. PubMed ID: 28586718
    [Abstract] [Full Text] [Related]

  • 11. Design, synthesis and biological evaluation of benzo[cd]indol-2(1H)-ones derivatives as BRD4 inhibitors.
    Feng Y, Xiao S, Chen Y, Jiang H, Liu N, Luo C, Chen S, Chen H.
    Eur J Med Chem; 2018 May 25; 152():264-273. PubMed ID: 29730189
    [Abstract] [Full Text] [Related]

  • 12. Discovery and characterization of bromodomain 2-specific inhibitors of BRDT.
    Yu Z, Ku AF, Anglin JL, Sharma R, Ucisik MN, Faver JC, Li F, Nyshadham P, Simmons N, Sharma KL, Nagarajan S, Riehle K, Kaur G, Sankaran B, Storl-Desmond M, Palmer SS, Young DW, Kim C, Matzuk MM.
    Proc Natl Acad Sci U S A; 2021 Mar 02; 118(9):. PubMed ID: 33637650
    [Abstract] [Full Text] [Related]

  • 13. Discovery of novel small molecule induced selective degradation of the bromodomain and extra-terminal (BET) bromodomain protein BRD4 and BRD2 with cellular potencies.
    Jiang F, Wei Q, Li H, Li H, Cui Y, Ma Y, Chen H, Cao P, Lu T, Chen Y.
    Bioorg Med Chem; 2020 Jan 01; 28(1):115181. PubMed ID: 31767403
    [Abstract] [Full Text] [Related]

  • 14. Design, synthesis and biological evaluation of imidazolopyridone derivatives as novel BRD4 inhibitors.
    Yang Y, Chen P, Zhao L, Zhang B, Xu C, Zhang H, Zhou J.
    Bioorg Med Chem; 2021 Jan 01; 29():115857. PubMed ID: 33191086
    [Abstract] [Full Text] [Related]

  • 15. 3-Hydroxyisoindolin-1-one derivates: Synthesis by palladium-catalyzed CH activation as BRD4 inhibitors against human acute myeloid leukemia (AML) cells.
    Chen P, Yang Y, Yang L, Tian J, Zhang F, Zhou J, Zhang H.
    Bioorg Chem; 2019 May 01; 86():119-125. PubMed ID: 30690335
    [Abstract] [Full Text] [Related]

  • 16. Design, synthesis and biological evaluation of novel indole derivatives as potential HDAC/BRD4 dual inhibitors and anti-leukemia agents.
    Cheng G, Wang Z, Yang J, Bao Y, Xu Q, Zhao L, Liu D.
    Bioorg Chem; 2019 Mar 01; 84():410-417. PubMed ID: 30554080
    [Abstract] [Full Text] [Related]

  • 17. Development of small-molecule BRD4 degraders based on pyrrolopyridone derivative.
    Zhang J, Chen P, Zhu P, Zheng P, Wang T, Wang L, Xu C, Zhou J, Zhang H.
    Bioorg Chem; 2020 Jun 01; 99():103817. PubMed ID: 32361153
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Design, synthesis, and biological evaluation of 4,5-dihydro-[1,2,4]triazolo[4,3-f]pteridine derivatives as novel dual-PLK1/BRD4 inhibitors.
    Wang NY, Xu Y, Xiao KJ, Zuo WQ, Zhu YX, Hu R, Wang WL, Shi YJ, Yu LT, Liu ZH.
    Eur J Med Chem; 2020 Apr 01; 191():112152. PubMed ID: 32088495
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.